TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors
- PMID: 12097257
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors
Abstract
The chromosome 17q23 region is frequently amplified in breast tumors. Gain of the region is present in 50% of BRCA1-associated breast tumors and 87% of BRCA2-associated breast tumors. The amplification frequency of the RPS6KB1 and TBX2 oncogenes from this amplicon was compared in 27 BRCA1 and BRCA2 mutant breast tumors, 15 breast tumors from high-risk patients with no BRCA1 or BRCA2 mutations, and 62 matched sporadic breast tumor controls. TBX2 was determined to be preferentially amplified and overexpressed in BRCA1 and BRCA2 mutant tumors, whereas RPS6KB1 was not, suggesting a role for TBX2 amplification in the development of BRCA1- and BRCA2-associated breast tumors.
Similar articles
-
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.Genes Chromosomes Cancer. 2004 Sep;41(1):1-11. doi: 10.1002/gcc.20057. Genes Chromosomes Cancer. 2004. PMID: 15236312
-
Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14. Clin Cancer Res. 2003. PMID: 14506147
-
Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.Hum Mutat. 2005 Mar;25(3):319. doi: 10.1002/humu.9308. Hum Mutat. 2005. PMID: 15712267
-
Histopathology of BRCA1- and BRCA2-associated breast cancer.Crit Rev Oncol Hematol. 2006 Jul;59(1):27-39. doi: 10.1016/j.critrevonc.2006.01.006. Epub 2006 Mar 10. Crit Rev Oncol Hematol. 2006. PMID: 16530420 Review.
-
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations.Oncogene. 2006 Sep 25;25(43):5837-45. doi: 10.1038/sj.onc.1209875. Oncogene. 2006. PMID: 16998498 Review.
Cited by
-
The orthologous Tbx transcription factors Omb and TBX2 induce epithelial cell migration and extrusion in vivo without involvement of matrix metalloproteinases.Oncotarget. 2014 Dec 15;5(23):11998-2015. doi: 10.18632/oncotarget.2426. Oncotarget. 2014. PMID: 25344916 Free PMC article.
-
Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families.Int J Oncol. 2012 Nov;41(5):1619-27. doi: 10.3892/ijo.2012.1595. Epub 2012 Aug 21. Int J Oncol. 2012. PMID: 22923021 Free PMC article.
-
Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2.Mol Cell Biol. 2008 Dec;28(24):7263-73. doi: 10.1128/MCB.00313-08. Epub 2008 Oct 20. Mol Cell Biol. 2008. PMID: 18936168 Free PMC article.
-
The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor.Cell Div. 2016 Apr 22;11:6. doi: 10.1186/s13008-016-0019-0. eCollection 2016. Cell Div. 2016. PMID: 27110270 Free PMC article.
-
The level of BMP4 signaling is critical for the regulation of distinct T-box gene expression domains and growth along the dorso-ventral axis of the optic cup.BMC Dev Biol. 2006 Dec 15;6:62. doi: 10.1186/1471-213X-6-62. BMC Dev Biol. 2006. PMID: 17173667 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous